FDA Drug Review Staff Split On Avandia's CV Safety In RECORD Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Disagreement within Office of New Drugs builds on differences between OND and drug safety staff publicized at 2007 advisory committee review.